FDA NDC Directory · JSON-LD · Markdown

JUBEREQ

NDC 69448-022 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namedenosumab-desu
Labeler / ManufacturerAccord BioPharma Inc.
Marketing categoryBiologic License Application · App BLA761424
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsDENOSUMAB (70 mg/mL)
Marketing started20260713
Package count1

External sources

Source: openFDA. Public-domain (CC0).